torticolli
trismu
uncommon
drool
occur
patient
evid
pharyng
tonsil
cervic
lymphaden
examin
report
proport
patient
symptom
indic
airway
obstruct
difficulti
breath
stridor
rel
small
airway
obstruct
context
retropharyng
abscess
predomin
occur
infant
young
children
peripher
blood
leukocytosi
common
e
crp
level
erythrocyt
sediment
rate
esr
usual
elev
case
enlarg
retropharyng
spaceprevertebr
tissu
seen
incid
retropharyng
abscess
increas
past
decad
similar
observ
report
uk
retropharyng
abscess
children
predomin
result
infect
suppur
retropharyng
chain
lymph
node
drain
nasopharynx
paranas
sinus
adenoid
common
primari
infect
includ
pharyng
tonsil
aden
less
frequent
sinus
otiti
media
mastoid
dental
infect
unlik
adult
local
trauma
foreign
bodi
ingest
play
rel
minor
role
children
c
clinic
manifest
differenti
diagnosi
common
present
featur
includ
pyrexia
sore
throat
dysphagia
odynophagia
neck
pain
neck
swell
limit
neck
mobil
particularli
extens
part
ii
clinic
syndrom
cardin
featur
infecti
diseas
approach
diagnosi
initi
manag
perform
use
transor
approach
less
commonli
use
transcerv
rout
complic
prognosi
potenti
complic
includ
airway
obstruct
intern
jugular
vein
thrombosi
mycot
aneurysm
carotid
arteri
aspir
pneumonia
mediastin
sepsi
although
rare
overal
j
patient
requir
repeat
surgic
intervent
patient
uncompl
cours
discharg
oral
antibiot
within
day
fatal
outcom
rare
recent
studi
later
pharyng
space
ie
parapharyng
space
shape
like
invert
cone
extend
base
skull
hyoid
bone
bound
medial
superior
pharyng
constrictor
muscl
later
intern
pterygoid
muscl
later
pharyng
space
contain
intern
carotid
arteri
intern
jugular
vein
cranial
nerv
ix
xii
sympathet
chain
lymph
node
space
separ
retropharyng
space
alar
fascia
provid
littl
barrier
spread
infect
simultan
infect
compart
common
investig
plain
later
neck
radiograph
fig
howev
ct
sensit
imag
modal
choic
manag
consensu
optim
empir
antibiot
treatment
penicillin
ampicillin
alon
insuffici
organ
aureu
mix
infect
common
appropri
empir
antibiot
regimen
includ
secondor
thirdgener
cephalosporin
plu
clindamycin
metronidazol
amoxicillinclavulan
ampicillinsulbactam
piperacillintazobactam
f
physician
think
clindamycin
alon
may
suffici
local
pattern
suscept
aureu
clinic
state
patient
taken
account
frequent
lead
combin
antibiot
includ
clindamycin
vancomycin
role
surgic
drainag
remain
controversi
g
patient
signific
respiratori
distress
requir
urgent
airway
manag
surgic
drainag
howev
debat
whether
trial
conserv
manag
intraven
antibiot
period
conjunct
close
monitor
appropri
patient
stabl
respiratori
distress
report
success
rate
conserv
manag
alon
vari
consider
studi
random
trial
h
surgic
drainag
usual
appear
male
predomin
case
predispos
ill
case
diseas
process
begin
primari
focu
infect
oropharynx
eg
palatin
tonsil
peritonsillar
tissu
infect
head
neck
area
includ
sinus
otiti
mastoid
parot
odontogen
infect
less
common
sourc
p
infect
subsequ
spread
later
pharyng
space
parapharyng
space
progress
result
infecti
thrombophleb
intern
jugular
vein
caus
septic
pulmonari
emboli
metastat
infect
distant
site
lung
commonli
involv
secondari
site
follow
joint
soft
tissu
infect
manifest
skin
infect
osteomyel
liver
abscess
splenic
abscess
mening
rare
clinic
manifest
differenti
diagnosi
present
featur
lemierr
syndrom
depend
partli
primari
site
infect
case
diagnos
within
day
onset
primari
infect
patient
oropharyng
sourc
inspect
may
reveal
exud
tonsil
hyperemia
grayish
pseudomembran
unremark
oropharyng
appear
time
septicemia
rule
lemierr
syndrom
patient
otiti
media
mastoid
primari
focu
otorrhea
postauricular
fluctuat
patient
highgrad
pyrexia
present
although
fever
absent
neck
swell
tender
seen
case
symptom
sign
includ
trismu
dysphagia
dyspnea
hemoptysi
pleurit
chest
pain
nausea
vomit
jaundic
hepatomegali
hypotens
sever
shock
renal
failur
uncommon
despit
septicem
state
auscult
percuss
chest
may
reveal
crepit
evid
pleural
effus
case
pulmonari
involv
wbc
count
crp
esr
often
markedli
elev
q
thrombocytopenia
occur
approxim
quarter
patient
level
liver
enzym
bilirubin
sometim
elev
blood
cultur
typic
posit
may
steril
patient
taken
antibiot
sampl
collect
cultur
contrastenhanc
ct
neck
use
investig
possibl
ct
find
includ
distend
neck
vein
intralumin
fill
defect
soft
tissu
swell
doppler
ultrasonographi
magnet
reson
imag
also
use
set
chest
radiograph
chest
ct
may
reveal
pulmonari
infiltr
pulmonari
cavit
pleural
effus
fig
manag
antibiot
treatment
mainstay
therapi
common
empir
regimen
includ
highdos
penicillin
metronidazol
clindamycin
ticarcillinclavulan
ampicillinsulbactam
r
due
endovascular
natur
infect
intraven
therapi
requir
sever
week
surgic
debrid
necrot
tissu
drainag
abscess
empyema
often
requir
conjunct
medic
therapi
ligat
resect
intern
jugular
vein
common
therapeut
intervent
preantibiot
era
howev
rare
necessari
restrict
unstabl
patient
fail
respond
conserv
therapi
role
routin
anticoagul
therapi
lemierr
syndrom
continu
controversi
complic
prognosi
metastat
infect
caus
complic
depend
locat
pleural
effus
empyema
lung
abscess
pulmonari
cavit
occur
patient
lemierr
syndrom
pneumatocel
pneumothorax
occur
septic
pyogen
arthriti
typic
affect
larger
joint
shoulder
elbow
hip
joint
see
fig
renal
involv
associ
proteinuria
hematuria
preantibiot
era
prognosi
poor
fatal
rate
high
histor
report
recent
review
literatur
suggest
fatal
outcom
uncommon
typic
think
distinct
parapharyng
retropharyng
abscess
meaning
clinic
etiolog
agent
epidemiolog
pathogenesi
spectrum
frequenc
caus
organ
similar
report
retropharyng
abscess
studi
deep
neck
space
infect
children
suggest
parapharyng
abscess
less
common
retropharyng
abscess
unlik
retropharyng
abscess
parapharyng
abscess
occur
age
group
without
predilect
younger
children
parapharyng
abscess
thought
result
primarili
infect
subsequ
suppur
lymph
node
later
pharyng
space
part
lymphat
drainag
nasopharynx
middl
ear
mani
case
histori
preced
pharyng
tonsil
clinic
manifest
differenti
diagnosi
clinic
featur
parapharyng
abscess
close
resembl
associ
retropharyng
abscess
fever
neck
swell
common
patient
also
dysphagia
odynophagia
torticolli
trismu
k
common
featur
distinguish
parapharyng
abscess
retropharyng
abscess
deviat
later
wall
oropharynx
midlin
oral
inspect
peripher
blood
leukocytosi
elev
crp
level
common
contrastenhanc
ct
imag
modal
choic
investig
suspect
case
l
plain
later
neck
radiograph
use
manag
complic
prognosi
manag
parapharyng
abscess
similar
retropharyng
abscess
ongo
controversi
among
expert
whether
surgeri
mandatori
patient
tradit
extern
cervic
approach
use
drainag
parapharyng
abscess
transor
drainag
report
safe
effect
select
case
abscess
locat
medial
great
vessel
transor
approach
cosmet
advantag
intraop
time
usual
shorter
potenti
complic
compris
intern
jugular
vein
thrombosi
eros
carotid
arteri
airway
obstruct
aspir
pneumonia
pleural
empyema
mediastin
pericard
septic
shock
n
fatal
outcom
longterm
sequela
rare
first
descript
lemierr
syndrom
publish
courmont
cade
follow
report
clinic
syndrom
also
refer
necrobacillosi
name
honor
lemierr
describ
seri
case
postangin
septicemia
lemierr
syndrom
character
primari
infect
oropharynx
blood
cultureconfirm
septicemia
evid
thrombophleb
intern
jugular
vein
metastat
infect
one
distant
site
etiolog
agent
fusobacterium
necrophorum
far
commonli
implic
etiolog
agent
case
lemierr
syndrom
f
necrophorum
oblig
anaerob
gramneg
bacillu
part
normal
flora
oral
caviti
gastrointestin
femal
genit
tract
strain
suscept
secondand
thirdgener
cephalosporin
clindamycin
metronidazol
signific
proport
clinic
isol
produc
caus
bacteria
associ
lemierr
syndrom
includ
fusobacterium
speci
bacteroid
speci
prevotella
speci
streptococci
mainli
nongroup
infrequ
staphylococci
mix
infect
also
occur
epidemiolog
pathogenesi
despit
absenc
solid
epidemiolog
data
expert
agre
incid
diseas
declin
consider
antibiot
era
lemierr
syndrom
current
uncommon
estim
annual
incid
approxim
case
per
million
peopl
howev
data
suggest
incid
increas
recent
year
diseas
typic
affect
teenag
young
adult
although
case
infanc
describ
epidemiolog
pathogenesi
prehib
vaccin
era
incid
epiglott
peak
earli
childhood
typic
affect
children
younger
year
age
institut
univers
hib
vaccin
peak
incid
shift
toward
older
age
group
simultan
increas
proport
adult
case
u
mani
studi
show
sex
predomin
other
report
male
predomin
littl
season
variat
incid
temper
climat
acut
epiglott
local
invas
bacteri
infect
supraglott
area
compris
epiglotti
arytenoid
cartilag
aryepiglott
fold
fals
vocal
chord
inflamm
result
airway
edema
narrow
lead
airway
obstruct
manifest
stridor
respiratori
distress
local
infect
evolv
phlegmon
abscess
format
bacteremia
common
case
caus
hib
dissemin
distant
site
eg
caus
septic
arthriti
mening
rare
incid
invas
haemophilu
influenza
type
b
hib
diseas
decreas
dramat
epiglott
ie
supraglott
becom
rare
diseas
countri
hib
vaccin
use
routin
data
england
wale
show
incid
invas
hib
diseas
decad
routin
immun
fell
case
per
inhabit
necrot
epiglott
rare
variant
report
predomin
among
immunocompromis
patient
etiolog
agent
hib
infect
account
approxim
epiglott
case
prehib
vaccin
era
controversi
rct
address
question
howev
previou
uncontrol
studi
shown
clear
benefit
regard
need
intub
durat
ventil
durat
hospit
stay
case
confirm
hib
epiglott
prophylaxi
rifampin
consid
household
contact
accord
american
academi
pediatr
recommend
latest
uk
guidelin
also
recommend
use
rifampin
suggest
ciprofloxacin
azithromycin
altern
peopl
toler
rifampin
rifampin
interfer
drug
complic
prognosi
potenti
complic
includ
complet
airway
obstruct
cardiac
arrest
epiglott
abscess
deep
neck
infect
pneumonia
seizur
patient
requir
short
period
intub
ventil
extub
hour
mortal
rate
less
set
good
intens
care
support
avail
croup
viral
croup
ie
laryngotrach
common
caus
infecti
upper
airway
obstruct
young
children
physician
prefer
divid
croup
spasmod
croup
laryngotrach
also
refer
laryngotracheobronch
howev
clinic
set
distinct
particularli
meaning
croup
therefor
use
chapter
etiolog
agent
epidemiolog
parainfluenza
viru
type
common
caus
agent
croup
account
case
follow
influenza
influenza
b
respiratori
syncyti
viru
less
common
etiolog
agent
includ
adenovirus
rhinovirus
coxsackievirus
echovirus
studi
associ
human
metapneumoviru
human
bocaviru
human
coronaviru
croup
data
suggest
clinic
cours
croup
caus
influenza
viru
sever
croup
caus
parainfluenza
viru
epidemiolog
pathogenesi
croup
common
one
studi
seattl
estim
annual
incid
high
case
per
children
younger
year
age
incid
croup
highest
among
children
age
month
year
typic
croup
symptom
rare
observ
children
older
year
age
like
increas
airway
diamet
incid
higher
among
boy
temper
climat
incid
typic
peak
late
autumn
winter
inflammatori
edema
mucu
product
result
airway
narrow
subglott
region
result
stridor
inflamm
vocal
chord
result
hoars
sometim
aphonia
typic
featur
croup
inspiratori
stridor
bark
cough
hoars
symptom
often
start
abruptli
typic
worsen
night
nonspecif
coryz
symptom
frequent
preced
ill
patient
lowgrad
moderategrad
fever
less
case
primari
care
set
requir
hospit
infecti
noninfecti
caus
clinic
featur
upper
airway
obstruct
includ
croup
delin
chapter
see
tabl
noninfecti
differenti
diagnosi
includ
foreign
bodi
aspir
vocal
chord
dysfunct
laryng
web
allerg
hypocalcem
laryngospasm
subglott
stenosi
eg
prolong
intub
tracheomalacia
htype
tracheoesophag
fistula
gastroesophag
reflux
vascular
ring
laryng
diphtheria
rare
potenti
lifethreaten
infect
begin
sever
croup
diagnosi
croup
made
primarili
clinic
ground
airway
chest
radiograph
indic
case
uncompl
croup
howev
radiograph
show
narrow
subglott
airway
use
altern
diagnosi
suspect
respiratori
viral
panel
test
pcr
confirm
typic
agent
frequent
aid
manag
manag
treatment
mist
humidifi
air
key
compon
croup
manag
much
centuri
although
publish
rct
investig
effect
humidifi
air
hospit
patient
publish
data
effect
warm
humidifi
air
home
environmenta
measur
frequent
recommend
parent
clinic
manifest
diagnosi
children
epiglott
typic
look
system
unwel
highgrad
fever
stridor
aphonia
hoars
muffl
hot
potato
voic
common
featur
odynophagia
common
drool
frequent
observ
patient
assum
upright
tripod
posit
forward
lean
extens
neck
cervic
lymphadenopathi
also
common
featur
peripher
blood
leukocytosi
present
case
later
neck
radiograph
demonstr
epiglott
enlarg
distend
hypopharynx
classic
thumb
sign
high
sensit
fig
howev
attempt
stabl
cooper
patient
safe
environ
perform
radiographi
later
posit
precipit
respiratori
arrest
complet
airway
obstruct
especi
child
neck
reposit
optim
result
manag
effect
airway
manag
critic
upset
child
attempt
inspect
oropharynx
result
complet
airway
obstruct
nebul
epinephrin
ie
adrenalin
provid
transient
improv
respiratori
distress
also
caus
agit
precipit
airway
obstruct
unstabl
patient
urgent
intub
direct
laryngoscopi
bronchoscopi
control
set
ie
oper
room
intens
care
unit
although
rare
requir
facil
perform
tracheostomi
must
avail
case
attempt
intub
fail
continu
controversi
whether
case
mild
end
diseas
spectrum
without
signific
respiratori
distress
manag
safe
without
intub
close
monitor
blood
cultur
throat
epiglott
swab
intub
case
obtain
cultur
suscept
test
empir
antibiot
therapi
thirdgener
cephalosporin
ampicillinsulbactam
commenc
promptli
v
routin
use
corticosteroid
intend
reduc
airway
edema
remain
acut
laryng
previous
healthi
peopl
usual
selflimit
viral
diseas
treatment
antibiot
routin
indic
cochran
review
topic
includ
two
rct
evalu
penicillin
v
erythromycin
versu
placebo
conclud
routin
antibiot
treatment
proven
benefit
term
bacteri
tracheiti
first
use
public
jone
colleagu
earlier
report
describ
case
laryngotracheobronch
close
resembl
descript
bacteri
tracheiti
suggest
entiti
recogn
previous
etiolog
agent
aureu
far
common
caus
organ
bacteria
commonli
implic
bacteri
tracheiti
pyogen
pneumonia
h
influenza
catarrhali
case
attribut
varieti
bacteria
includ
pseudomona
aeruginosa
bacillu
cereu
escherichia
coli
prevotella
speci
bacteroid
speci
also
report
although
appear
uncommon
epidemiolog
pathogenesi
bacteri
tracheiti
rare
estim
annual
incid
case
per
children
unit
kingdom
australia
incid
data
publish
countri
data
suggest
incid
peak
autumn
winter
bacteri
tracheiti
predomin
affect
young
children
although
adult
case
describ
pathogenesi
bacteri
tracheiti
remain
unclear
postul
viral
infect
upper
respiratori
tract
may
facilit
secondari
bacteri
infect
invas
airway
result
inflamm
edema
ultim
lead
narrow
trachea
peak
incid
bacteri
tracheiti
coincid
peak
season
viral
respiratori
pathogen
suggest
synergi
one
larg
case
seri
coinfect
influenza
viru
identifi
almost
one
third
case
coinfect
parainfluenza
viru
respiratori
syncyti
viru
adenoviru
describ
report
clinic
manifest
differenti
diagnosi
patient
bacteri
tracheiti
report
prodrom
symptom
suggest
minor
upper
respiratori
tract
infect
typic
began
day
onset
stridor
stridor
dyspnea
develop
patient
often
deterior
rapidli
frequent
requir
intub
within
first
hour
overcom
increas
upper
airway
obstruct
common
featur
present
includ
fever
often
moder
high
grade
hoars
voic
aphonia
cough
intercost
subcost
recess
drool
uncommon
case
show
littl
respons
nebul
epinephrin
main
differenti
diagnos
epiglotti
viral
croup
unlik
case
bacteri
tracheiti
children
epiglott
typic
refus
speak
drool
adopt
upright
posit
extens
neck
children
croup
typic
lowgrad
pyrexia
appear
toxic
usual
respond
nebul
epinephrin
inflammatori
respons
includ
elev
crp
level
wbc
count
seen
patient
present
radiograph
may
demonstr
narrow
tracheal
air
shadow
intralumin
tracheal
membran
although
univers
find
fig
coexist
pulmonari
chang
includ
infiltr
atelectas
common
direct
visual
airway
reveal
unremark
mildli
inflam
epiglotti
show
mark
subglott
inflamm
edema
tracheal
mucosa
copiou
purul
endotrach
secret
endotrach
aspir
obtain
sent
bacteri
cultur
suscept
test
blood
cultur
rare
help
bacteremia
rel
uncommon
patient
manag
proactiv
airway
manag
critic
manag
bacteri
tracheiti
prevent
complet
airway
obstruct
consequ
respiratori
arrest
larger
publish
case
seri
patient
requir
intub
tracheostomi
mechan
ventil
intub
usual
challeng
requir
use
endotrach
tube
consider
smaller
diamet
would
expect
base
patient
age
personnel
equip
tracheostomi
must
readili
avail
case
convent
intub
fail
appropri
empir
antibiot
treatment
must
includ
effect
antistaphylococc
coverag
combin
thirdgener
cochran
review
includ
pool
data
three
rct
found
modest
statist
signific
improv
croup
sever
score
patient
receiv
humidifi
air
compar
untreat
patient
first
hour
treatment
differ
treatment
group
outcom
measur
treatment
corticosteroid
routin
indic
cochran
review
includ
rct
show
corticosteroid
treatment
associ
signific
improv
croup
sever
score
hour
compar
placebo
corticosteroid
treatment
associ
shorter
durat
stay
emerg
depart
hospit
fewer
admiss
fewer
return
visit
howev
rang
differ
corticosteroid
eg
dexamethason
budesonid
methylprednisolon
fluticason
differ
rout
administr
eg
oral
intramuscular
inhal
dose
use
trial
expert
recommend
use
oral
intramuscular
dexamethason
mgkg
nebul
budesonid
mg
remain
unclear
whether
repeat
dose
first
hour
improv
outcom
mani
studi
shown
nebul
epinephrin
effect
achiev
symptomat
improv
children
moder
sever
croup
data
suggest
use
nebul
epinephrin
result
consider
reduct
need
intub
tracheostomi
drug
administ
racem
epinephrin
ml
ml
salin
lepinephrin
solut
ml
cochran
review
conclud
two
drug
equal
effect
treatment
safe
side
effect
pallor
tachycardia
usual
mild
transient
children
moder
croup
ie
stridor
chest
wall
indraw
rest
fail
improv
suffici
within
hour
administr
corticosteroid
hospit
consid
children
sever
croup
receiv
dose
corticosteroid
treat
nebul
epinephrin
repeat
administr
nebul
epinephrin
may
necessari
intens
care
support
consid
insuffici
respons
effect
nebul
epinephrin
last
hour
clinic
symptom
return
baselin
becom
sever
ie
rebound
effect
children
oxygen
satur
room
air
given
supplement
oxygen
sever
report
describ
use
heliox
treat
croup
promis
result
howev
two
cochran
review
conclud
insuffici
evid
support
use
set
use
antituss
decongest
agent
recommend
treatment
antibiot
indic
unless
clinic
featur
laboratori
test
result
indic
secondari
bacteri
infect
case
sever
croup
caus
influenza
b
viru
treatment
neuraminidas
inhibitor
consid
although
insuffici
efficaci
data
approach
set
complic
prognosi
patient
croup
requir
intub
ventil
contigu
spread
viral
infect
occur
caus
otiti
media
bronchiol
pneumonia
bacteri
superinfect
lead
bacteri
tracheiti
discuss
later
bronchopneumonia
prognosi
uncompl
croup
good
symptom
larg
resolv
within
hour
patient
fatal
outcom
rare
isol
acut
laryng
primarili
diseas
describ
adolesc
adult
etiolog
agent
acut
laryng
caus
commonli
virus
spectrum
caus
agent
similar
croup
bacteria
implic
acut
laryng
includ
pneumonia
h
influenza
catarrhali
key
featur
acut
laryng
chang
normal
pitch
voic
hoars
typic
last
day
coexist
nonspecif
upper
respiratori
tract
infect
symptom
coryza
sore
throat
cough
common
cephalosporin
eg
ceftriaxon
cefotaxim
penicillinaseresist
penicillin
eg
cloxacillin
nafcillin
given
intraven
suitabl
choic
area
communityacquir
mrsa
infect
unlik
otherwis
vancomycin
replac
latter
compon
goodqual
evid
lack
mani
center
use
system
corticosteroid
first
day
ill
intent
reduc
airway
edema
patient
requir
ventilatori
support
day
unless
complic
occur
optim
durat
antibiot
treatment
unknown
expert
recommend
minimum
day
treatment
complic
prognosi
complic
bacteri
tracheiti
includ
pneumothorax
pneumomediastinum
pulmonari
edema
acut
respiratori
distress
syndrom
hypotens
cardiorespiratori
arrest
case
concurr
toxic
shock
syndrom
describ
neurolog
sequela
common
patient
experi
cardiorespiratori
arrest
subglott
stenosi
subglott
polyp
rare
longterm
sequela
bacteri
tracheiti
potenti
lifethreaten
condit
earli
public
report
case
fatal
excess
fatal
outcom
uncommon
past
decad
like
reflect
improv
intens
care
support
acut
bronchiti
predomin
occur
adolesc
adult
data
us
nation
health
interview
survey
suggest
approxim
adult
experi
one
episod
bronchiti
per
year
incid
peak
autumn
winter
etiolog
agent
case
bronchiti
nonbacteri
natur
although
caus
organ
identifi
mani
patient
viral
infect
appear
account
case
virus
commonli
implic
acut
bronchiti
includ
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
rhinoviru
adenoviru
human
metapneumoviru
infect
due
bacteri
organ
includ
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
less
common
clinic
manifest
manag
ill
typic
begin
nonspecif
upper
respiratori
tract
infect
symptom
usual
last
day
follow
second
phase
character
persist
cough
frequent
sputum
product
wheez
typic
last
week
antibiot
therapi
routin
indic
previous
healthi
peopl
acut
bronchiti
cochran
review
includ
nine
rct
show
antibiot
treatment
averag
reduc
durat
cough
less
day
compar
placebo
advers
effect
significantli
common
antibiotictr
patient
updat
review
includ
rct
conclud
benefit
antibiot
treatment
bronchiti
margin
guidelin
treat
acut
bronchiti
american
colleg
physician
american
colleg
chest
physician
discourag
routin
use
antibiot
inhal
bronchodil
mucolyt
agent
howev
patient
diagnos
pertussi
receiv
azithromycin
primarili
limit
transmiss
